Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B

MLA

Rivero-Calle I, et al. “Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria Meningitidis Serogroup B.” Infection and Drug Resistance, vol. ume 12, Oct. 2019, pp. 3169–88. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.2d73e8fb0b8a483aac342532e5b686c5&authtype=sso&custid=ns315887.

APA

Rivero-Calle I, Raguindin PF, Gómez-Rial J, Rodriguez-Tenreiro C, & Martinón-Torres F. (2019). Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria meningitidis Serogroup B. Infection and Drug Resistance, ume 12, 3169–3188.

Chicago

Rivero-Calle I, Raguindin PF, Gómez-Rial J, Rodriguez-Tenreiro C, and Martinón-Torres F. 2019. “Meningococcal Group B Vaccine For The Prevention Of Invasive Meningococcal Disease Caused By Neisseria Meningitidis Serogroup B.” Infection and Drug Resistance ume 12 (October): 3169–88. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.2d73e8fb0b8a483aac342532e5b686c5&authtype=sso&custid=ns315887.